Exelixis, Inc. ( EXEL) - Key Metrics

EXEL Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $2.51 $0.85 $1.23 $1.24
2026Q1 $2.36 $0.81 $0.97 $0.97
2025Q4 $2.20 $0.90 $1.23 $1.22
2025Q3 $2.23 $0.72 $1.08 $1.08
2025Q2 $2.08 $0.68 $0.18 $0.17

EXEL Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 16.43
2026Q1 0% 13.54
2025Q4 0% 11.97
2025Q3 0% 13.92
2025Q2 0% 16.97

EXEL Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 2.21% 0%
2026Q1 2.20% 0%
2025Q4 2.81% 0%
2025Q3 2.68% 0%
2025Q2 0.36% 0%

EXEL

Price: $59.86

52 week price:
33.76
61.14

Earnings Per Share: 3.18 USD

P/E Ratio: 16.14

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 986798

Ebitda: 84.9 million

Market Capitalization: 14.8 billion

Links: